Company Overview and News

 
Blockchain will speed up overseas shipping

5h thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
Upvote Downvote

 
The next mega merger could be a $60 billion drug deal

2018-04-19 money.cnn
Shares in Shire (SHPG) surged by as much as 12% on Thursday in London trading after two rival drugmakers said they were considering a bid for the biotech company.
Upvote Downvote

 
Acquisition Cycle Creates Value Opportunity With Molson Coors

2018-04-19 seekingalpha
The acquisition of Miller assets in 2016 has created what I call an acquisition cycle for Molson Coors.
Upvote Downvote

 
Blockchain Is About to Revolutionize the Shipping Industry - Bloomberg

2018-04-19 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
What to look for as Q1 earnings hit around the globe

2018-04-18 themalaymailonline
Johnson & Johnson says as a result of tax reform, it plans to increase spending on research and capital investment by 15 per cent over the next four years. — Reuters picNEW YORK, April 18 — Trade, taxes and China are the main themes to watch for heading into first-quarter earnings, along with a spate of potential deals.
Upvote Downvote

 
What to Look for as First-Quarter Earnings Hit Around the Globe - Bloomberg

2018-04-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

1
UPDATE 2-Consol tests South Africa optimism with up to $300 mln IPO

2018-04-16 reuters
JOHANNESBURG, April 16 (Reuters) - South African glass bottle maker Consol aims to raise up to $300 million in an initial public offering (IPO), it said on Monday, testing new-found enthusiasm in the country’s economy since Cyril Ramaphosa was elected president.
Upvote Downvote

 
32 'Safer' Dividend Consumer Defensive Stocks For April, 2019

2018-04-13 seekingalpha
32 of 91 top yield Consumer Defensive stocks were tagged "safer" because they showed positive annual-returns, and free cash-flow yields greater than their dividend yields.
Upvote Downvote

 
SAP revises pricing after crackdown on big customers backfires - Channel NewsAsia

2018-04-10 channelnewsasia
SAP is revising how it prices its core business planning software after a legal crackdown against high-profile customers Diageo and AB InBev caused a backlash with its wider customer base, who feared they might be hit by hidden, indirect charges.
Upvote Downvote

 
What's Hurting AB InBev (BUD) Stock Price After a Solid Q4?

2018-04-09 zacks
Anheuser-Busch InBev SA/NV (BUD - Free Report) , alias AB InBev, depicted great strength in fourth-quarter 2017, which was clear from the top- and bottom-line beat after dismal trends in the past. Though this turnaround was a welcome sign, the company’s commentary on soft results, anticipated in the first quarter of 2018, has kept investors’ enthusiasm at bay. Consequently, shares of AB InBev lost 5.
Upvote Downvote

 
U.S. Beer Opens a Can of Worms: Will Its Fizz Remain?

2018-04-06 zacks
Fears of an imminent U.S.-China trade war have shaken up a number of sectors. The beer industry too hasn’t been spared. President Donald Trump’s imposition of a 10% tariff on imported aluminum from China is likely to have a devastating effect on the U.S. beer industry. Given that most of the beer produced in the United States today is packaged in cans, aluminum tariffs will only make things difficult for the country’s beer industry.
Upvote Downvote

 
America’s 30 Oldest Beers

2018-04-05 247wallst
24/7 Wall St. identified the 30 oldest beers in America by reviewing all of the domestically-made beers owned by the three largest beer companies: Molson Coors Brewing Company, Pabst Brewing Company, and Anheuser-Busch InBev SA/NV. We also reviewed a handful of microbreweries that either predate the 20th century or started in its early years.
Upvote Downvote

 
America’s 30 Oldest Beers

2018-04-05 247wallst
24/7 Wall St. identified the 30 oldest beers in America by reviewing all of the domestically-made beers owned by the three largest beer companies: Molson Coors Brewing Company, Pabst Brewing Company, and Anheuser-Busch InBev SA/NV. We also reviewed a handful of microbreweries that either predate the 20th century or started in its early years.
Upvote Downvote

 
How Constellation Brands’ Margins Fared in Fiscal 4Q18

2018-04-04 editors.aws.marketrealist
Constellation Brands’ (STZ) gross margin declined 30 basis points to 48.1% in fiscal 4Q18, which ended on February 28, 2018. This decline was a result of higher depreciation expenses. For full-year fiscal 2018, the company’s gross margin expanded to 50.3% from 48.1% in fiscal 2017. This improvement was a result of glass and material sourcing benefits, favorable foreign currency movements, and supply independence from Anheuser-Busch InBev (BUD).
Upvote Downvote

 
How Analysts Reacted to Constellation Brands’ Q4 Results

2018-04-04 editors.aws.marketrealist
On April 3, Stifel downgraded Constellation Brands to “hold” from “buy.” Stifel also lowered its price target for Constellation Brands stock to $228 from $245. As of April 3, 17 out of 22 analysts covering Constellation Brands rated the stock a “buy.” Five analysts rated the stock a “hold,” and none of the analysts recommended a “sell.”
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...